- Home
- ADSK vs EW Comparison
ADSK vs EW Comparison
Compare ADSK & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADSK | EW |
|---|---|---|
| Founded | 1982 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.8B | 49.9B |
| IPO Year | 1994 | 1999 |
Fundamental Metrics
Financial Performance| Metric | ADSK | EW |
|---|---|---|
| Price | $217.72 | $85.22 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 26 | 21 |
| Target Price | ★ $335.04 | $96.37 |
| AVG Volume (30 Days) | 2.6M | ★ 3.9M |
| Earning Date | 05-21-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2.15 | N/A |
| EPS | ★ 2.32 | 0.66 |
| Revenue | ★ $7,206,000,000.00 | $6,067,600,000.00 |
| Revenue This Year | $15.35 | $13.39 |
| Revenue Next Year | $10.36 | $9.81 |
| P/E Ratio | ★ $93.99 | $130.29 |
| Revenue Growth | ★ 17.53 | 11.55 |
| 52 Week Low | $185.50 | $72.30 |
| 52 Week High | $329.09 | $96.29 |
Technical Indicators
Market Signals| Indicator | ADSK | EW |
|---|---|---|
| Relative Strength Index (RSI) | 57.49 | 38.94 |
| Support Level | $215.53 | $82.02 |
| Resistance Level | $250.50 | $87.69 |
| Average True Range (ATR) | 6.74 | 2.22 |
| MACD | 2.91 | -1.04 |
| Stochastic Oscillator | 87.11 | 2.06 |
Price Performance
Historical ComparisonAbout ADSK Autodesk Inc.
Founded in 1982, Autodesk is a multinational software company best known for pioneering computer-aided design, or CAD, with its AutoCAD product. Nowadays, Autodesk provides design software for a variety of verticals, including architecture & construction, manufacturing, and media & entertainment. Autodesk products have been used in some of the world's most iconic landmarks, like Burj Khalifa, and well-known movie titles like Avatar.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.